Scientists report thyroid cancer discovery

Nov 15, 2006

Canadian scientists say the discovery of a mutated protein in cells linked with thyroid cancer may lead to the development of drugs to fight such cancers.

"We now know why this gene causes these tumors and can start looking at how best to target the mutant proteins so that the cells expressing them can be killed or stopped from growing," said Queens University pathology and molecular medicine Professor Lois Mulligan, senior author of the study.

She and graduate student Taranjit Gujral developed three-dimensional models of the mutated RET protein implicated in a condition causing cancerous thyroid tumors. The model allowed them to predict and compare the protein's molecular actions and to see that the protein was 10 times more active than normal in cells associated with Multiple Endocrine Neoplasia 2B syndrome, an inherited cancer syndrome.

Vinay Singh and Zongchao Jia of the university's biochemistry department were co-authors of the study that appears in the journal Cancer Research.

Copyright 2006 by United Press International

Explore further: Genetics and lifestyle have a strong impact on biomarkers for inflammation and cancer

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Endogenous hormones improve breast cancer risk models

4 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

5 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments : 0